Outcome analysis using the KM plotter datasets revealed that BC patients who had a tumor with high CDCA5 mRNA expression had a worse survival rate compared with those who had low CDCA5 mRNA expression (p < 0.001, Hazard ratio (HR) 1.78, 95% CI; 1.52–2.07; Figure 2A). Here, CDCA5 is linked to breast cancer.